Latest filing published 17 Apr 2021 for VALEO PHARMA INC., €3,665.
Guy Paul Allard is a declared insider of Valeo Pharma Inc., with filings sourced from SEDI. Over a trading history stretching from 27 December 2018 to 14 April 2021, the count stands at 10 filings.
Both buying and selling appear: 8 purchases worth €8,971, against 1 sale worth €2,556. Purchases outweigh sales by €6,415. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2021 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €833. The 8 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The record was last updated on 17 April 2021 with an open-market purchase (€3,665) in Valeo Pharma Inc. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations